Abstract
An excess of adipose tissue, a characteristic of obesity, has been associated with endocrine-metabolic alterations that contribute to dyslipidemias, which are characterized by an increase in the plasma concentrations of triacylglycerols, total cholesterol, and LDL-c along with a reduction in HDL-c. Some nutrients such as the mineral magnesium play important roles in lipid metabolism. Magnesium regulates the activity of HMG-CoA reductase, increasing the activity of lipoprotein lipase and lecithin-cholesterol acyltransferase. The objective of this review is to present important aspects about the contribution of obesity to the manifestation of cardiovascular risk, to bring the main physiological functions of magnesium, as well as the role of the nutrient in the protection against cardiovascular diseases. Studies have shown that individuals with obesity have low intracellular concentrations of magnesium, which can compromise the nutrient’s physiological functions. Thus, this mineral appears to play an important role in protecting against cardiovascular diseases; however, changes in the nutrient metabolism in obesity may compromise the functions of this element. Further studies are needed to clarify this.
Similar content being viewed by others
References
El-Sayed Moustafa JS, Froguel P (2013) From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol 9(7):402–413
Oliveira AR, Cruz KJ, Morais JB, Severo JS, de Freitas TE, Veras AL, Rocha Romero AB, Colli C, Nogueira NN, Torres-Leal FL, Marreiro DN (2015) Magnesium status and its relationship with C-reactive protein in obese women. Biol Trace Elem Res 168(2):296–302
Mika A, Sledzinski T (2017) Alterations of specific lipid groups in serum of obese humans: a review. Obes Rev 18(2):247–272
Ranganathan S, Krishnan TUS, Radhakrishnan S (2015) Comparison of dyslipidemia among the normal-BMI and high-BMI group of people of rural Tamil Nadu. Med J DY Patil Univ 8(2):149–152
Manjunath CN, Rawal JR, Irani PM, Madhu K (2013) Atherogenic dyslipidemia. Indian J Endocrinol Metab 17(6):969–976
Misra A, Shrivastava U (2013) Obesity and dyslipidemia in South Asians. Nutrients 5(7):2708–2733
Cruz KJ, Oliveira AR, Pinto DP, Morais JB, Lima FS, Colli C, Torres-Leal FL, Marreiro DN (2014) Influence of magnesium on insulin resistance in obese women. Biol Trace Elem Res 160(3):305–310
Lefebvre P, Letois F, Sultan A, Nocca D, Mura T, Galtier F (2014) Nutrient deficiencies in patients with obesity considering bariatric surgery: a cross-sectional study. Surg Obes Relat Dis 10(3):540–546
Suliburska J, Cofta S, Gajewska E, Kalmus G, Sobieska M, Samborski W, Krejpcio Z, Drzymala-Czyz S, Bogdanski P (2013) The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci 17(17):2396–2400
Oliveira ARS, Cruz KJC, Severo JS, Morais JBS, Freitas TEC, Araújo RS, Marreiro DN (2017) Hypomagnesemia and its relation with chronic low-grade inflammation in obesity. Rev Assoc Med Bras 63(2):156–163
Severo JS, Morais JBS, Freitas TEC, Cruz KJC, Oliveira ARS, Poltronieri F, Marreiro DN (2015) Aspectos Metabólicos e Nutricionais do Magnésio. Nutr Clín Diet Hosp 35(2):67–74
Simental-Mendía LE, Simental-Mendía M, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 73(5):525–536
Rosanoff A, Seelig MS (2004) Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 23(5):501–505
Rotter I, Kosik-Bogacka D, Dołęgowska B, Safranow K, Karakiewicz B, Laszczyńska M (2015) Relationship between serum magnesium concentration and metabolic and hormonal disorders in middle-aged and older men. Magnes Res 28(3):99–107
Klop B, Elte JW, Cabezas MC (2013) Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5(4):1218–1240
Lima LM, Carvalho MG, Sousa MO (2007) Índice apoB/ap A-I e predição de risco cardiovascular. Arq Bras Cardiol 88(6):187–190
Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK (2014) Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J 66(3):280–288
Elmaoğullari S, Tepe D, Uçaktürk SA, Kara FK, Demirel F (2015) Prevalence of dyslipidemia and associated factors in obese children and adolescents. J Clin Res Pediatr Endocrinol 7(3):228–234
Qi Q, Strizich G, Hanna DB, Giacinto RE, Castañeda SF, Sotres-Alvarez D, Pirzada A, Llabre MM, Schneiderman N, Avilés-Santa LM, Kaplan RC (2015) Comparing measures of overall and central obesity in relation to cardiometabolic risk factors among US Hispanic/Latino adults. Obesity (Silver Spring) 23(9):1920–1928
Attané C, Peyot ML, Lussier R, Poursharifi P, Zhao S, Zhang D, Morin J, Pineda M, Wang S, Dumortier O, Ruderman NB, Mitchell GA, Simons B, Madiraju SRM, Joly E, Prentki M (2016) A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice. Diabetologia 59(12):2654–2663
Jung UJ, Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15(4):6184–6223
Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vasc Pharmacol 57(2-4):91–97
Schweiger M, Romauch M, Schreiber R, Grabner GF, Hütter S, Kotzbeck P, Benedikt P, Eichmann TO, Yamada S, Knittelfelder O, Diwoky C, Doler C, Mayer N, de Cecco W, Breinbauer R, Zimmermann R, Zechner R (2017) Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. Nat Commun 8:14859
Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21(6):697–738
Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS, Klein S (2009) Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 17(10):1872–1877
Roberts R, Hodson L, Dennis AL, Neville MJ, Humphreys SM, Harnden KE (2009) Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52(5):882–890
Scherer T, Lindtner C, Zielinski E, O’Hare J, Filatova N, Buettner C (2012) Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J Biol Chem 287(39):33061–33069
Saponaro C, Gaggini M, Carli F, Gastaldelli A (2015) The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7(11):9453–9474
Ebbert JO, Jensen MD (2013) Fat depots, free fatty acids, and dyslipidemia. Nutrients 5(2):498–508
Hussain MM (2014) Intestinal lipid absorption and lipoprotein formation. Curr Opin Lipidol 25(3):200–206
Hussain MM (2014) Regulation of intestinal lipid absorption by clock genes. Annu Rev Nutr 34:357–375
Ponziani FR, Pecere S, Gasbarrini A, Ojetti V (2015) Physiology and pathophysiology of liver lipid metabolism. Expert Rev Gastroenterol Hepatol 9(8):1055–1067
Clemente-Postigo M, Queipo-Ortuño MI, Fernandez-Garcia D, Gomez-Huelgas R, Tinahones FJ, Cardona F (2011) Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One 6(9):e24783
Klop B, Wouter Jukema J, Rabelink TJ, Castro Cabezas M (2012) A physician’s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med 54(2):91–103
Roberts CK, Barnard RJ, Liang KH, Vaziri ND (2002) Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. Atherosclerosis 161(1):133–141
Kobayashi J, Miyashita K, Nakajima K, Mabuchi H (2015) Hepatic lipase: a comprehensive view of its role on plasma lipid and lipoprotein metabolism. J Atheroscler Thromb 22(10):1001–1011
Miyashita K, Nakajima K, Fukamachi I, Muraba Y, Koga T, Shimomura Y, Machida T, Murakami M, Kobayashi J (2017) A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase. J Lipid Res 58(8):1591–1597
Subramanian S, Chait A (2012) Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta 1821(5):819–825
Franssen R, Monajemi H, Stroes ESG, Kastelein JPP (2011) Obesity and dyslipidemia. Med Clin N Am 95(5):893–902
Akoumianakis I, Antoniades C (2017) The interplay between adipose tissue and the cardiovascular system: is fat always bad? Cardiovasc Res 113(9):999–1008
Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN (2017) Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology. Atherosclerosis 263:361–368
Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Neto AA et al (2017) Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol 109(2 Supl 1):1–76
Libby P (2013) Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 368(21):2004–2013
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695
Molica F, Morel S, Kwak BR, Rohner-Jeanrenaud F, Steffens S (2015) Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost 113(3):553–566
Ridker PM (2016) From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res 118(1):145–156
Münzel T, Sinning C, Post F, Warnholtz A, Schulz E (2008) Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 40(3):180–196
Jahangir E, De Schutter A, Lavie CJ (2014) The relationship between obesity and coronary artery disease. Transl Res 164(4):336–344
Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M (2017) The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res 40(12):947–963
Geiger H, Wanner C (2012) Magnesium in disease. Clin Kidney J 5(Suppl 1):i25–i38
Zaakouka AM, Hassana AM, Tolba OA (2016) Serum magnesium status among obese children and adolescents. Gaz Egypt Paediatr Assoc 64(1):32–37
Guerrero-Romero F, Rodriguez-Moran M (2013) Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects. Eur J Intern Med 24(7):639–643
Farhangi MA, Ostadrahimi A, Mahboob S (2011) Serum calcium, magnesium, phosphorous and lipid profile in healthy Iranian premenopausal women. Biochem Med (Zagreb) 21(3):312–320
Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M (2013) PPARγ signaling and metabolism: the good, the bad and the future. Nat Med 19(5):557–566
Shen H, MacDonald R, Bruemmer D, Stromberg A, Daugherty A, Li XA (2007) Zinc deficiency alters lipid metabolism in LDL receptor deficient mice treated with rosiglitazone. J Nutr 137(11):2339–2345
Altura BM, Shah NC, Li Z, Jiang XC, Perez-Albela JL, Altura BT (2010) Magnesium deficiency upregulates serine palmitoyl transferase (SPT 1 and SPT 2) in cardiovascular tissues: relationship to serum ionized Mg and cytochrome c. Am J Physiol Heart Circ Physiol 299(3):H932–H938
Wei CC, Wu K, Gao Y, Zhang LH, Li DD, Luo Z (2017) Magnesium reduces hepatic lipid accumulation in yellow catfish (Pelteobagrus fulvidraco) and modulates lipogenesis and lipolysis via PPARA, JAK-STAT, and AMPK pathways in hepatocytes. J Nutr 147(6):1070–1078
Gueux E, Rayssiguier Y, Piot MC, Alcindor L (1984) Reduction of plasma lecithin--cholesterol acyltransferase activity by acute magnesium deficiency in the rat. J Nutr 114(8):1479–1483
Das UN (2010) Delta6 desaturase as the target of the beneficial actions of magnesium. Med Sci Monit 16(8):11–12
Mahfouz MM, Kummerow FA (1989) Effect of magnesium deficiency on delta 6 desaturase activity and fatty acid composition of rat liver microsomes. Lipids 24(8):727–732
Rayssiguier Y, Gueux E, Weiser D (1981) Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J Nutr 111(11):1876–1883
Luthringer C, Rayssiguier Y, Gueux E, Berthelot A (1988) Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats. Br J Nutr 59(2):243–250
DiNicolantonio JJ, O’Keefe JH, Wilson W (2018) Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart 5(1):e000668
Guerrero-Romero F, Flores-García A, Saldaña-Guerrero S, Simental-Mendía LE, Rodríguez-Morán M (2016) Obesity and hypomagnesemia. Eur J Intern Med 34:29–33
Gröber U, Schmidt J, Kisters K (2015) Magnesium in prevention and therapy. Nutrients 7(9):8199–8226
Vierling W, Liebscher DH, Micke O, von Ehrlich B, Kisters K (2013) Magnesium deficiency and therapy in cardiac arrhythmias: recommendations of the German Society for Magnesium Research. Dtsch Med Wochenschr 138(22):1165–1171
Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH (2014) Role of magnesium in cardiovascular diseases. Cardiol Rev 22(4):182–192
Gimenez MS, Oliveros LB, Gomez NN (2011) Nutritional deficiencies and phospholipid metabolism. Int J Mol Sci 12(4):2408–2433
Shechter M (2010) Magnesium and cardiovascular system. Magnes Res 23(2):60–72
Jun S, Cowan AE, Bhadra A, Dodd KW, Dwyer JT, A Eicher-Miller HÁ et al (2020) Older adults with obesity have higher risks of some micronutrient inadequacies and lower overall dietary quality compared to peers with a healthy weight, National Health and Nutrition Examination Surveys (NHANES), 2011-2014. Public Health Nutr 23(13):2268–2279
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
dos Santos, L.R., Melo, S.R.d., Severo, J.S. et al. Cardiovascular Diseases in Obesity: What is the Role of Magnesium?. Biol Trace Elem Res 199, 4020–4027 (2021). https://doi.org/10.1007/s12011-020-02528-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-020-02528-7